Latest News
Belgian Brain Council launches ‘Brain Art Challenge’
The Belgian Brain Council and partners invite all to join the competition with the aim to increase awareness about brain research and brain disorders and to fund a medico-social project for persons living with a brain condition. All details are below:
Exciting EBC agenda at FENS Forum 2018
EBC will be present at the upcoming FENS Forum 2018 starting this coming Saturday, 7 July, in Berlin, Germany. FENS, a founding member of EBC, is the voice of Neuroscience in Europe. With 43 neuroscience member societies across 33 European countries, FENS as an organisation represents close to 23.000 European neuroscientists with a clear mission to advance European neuroscience education [...]
EBC at EAN Congress 2018
EBC was happy to take part in the 4th Congress of the European Academy of Neurology, which took place from 16-19 June in Lisbon, Portugal. EBC was present in the exhibition hall to raise awareness of the work being done in Brussels with the recently released Brain Mission and brain research advocacy work, as well as to continue dissemination of [...]
EBC holds 1st General Assembly of 2018
Delegates to the General Assembly of the European Brain Council (EBC) met on 23rd-24th May 2018 in Brussels to address the key activities and projects of the organization. Amongst others, delegates were presented progress reports on a number of current issues such as: the EBC Strategic Plan, the ongoing development of the Value of Treatment (VoT) project, EBC’s advocacy strategy [...]
EBC at Neuro Convention 2018
On 6 and 7 June this coming week, EBC has been invited to exhibit at the European Neuro Convention 2018 in London, UK. EBC joins over 100 innovative exhibitors, from startup organisations to large multinational companies, the convention brings together a world-class selection of suppliers – all of which will be exhibiting their groundbreaking innovations that are helping to better the [...]
Professor Marc Dooms presents the GOLUP declaration at the ECRD
On 10th-12th May 2018, EURORDIS hosted the ninth European Conference on Rare Diseases & Orphan Products (ECRD) in Vienna, welcoming almost 1000 participants from more than 50 countries. In between the various panel discussions, Professor Marc Dooms, author of the Declaration on Good Off-Label Use Practices, known as the GOLUP (Good Off-Label Use Practice) was there to introduce participants to [...]
MULTI-ACT project launches today
MULTI-ACT Project brings research closer to patients and society The EU-funded MULTI-ACT project aiming to increase the impact of health research on people with brain diseases kicks off today. It will create and implement a new model allowing for the effective cooperation of all relevant stakeholders and be applicable in defining the scope of health research and innovation [...]
VoT featured in latest WHO Bulletin
The WHO Bulletin is one of the world's leading public health journals. It is a peer-reviewed monthly journal and one of the top public and environmental health journals with an impact factor of 4.939 (2016). This month, in the May edition, the findings of the EBC project on The Value of Treatment of Brain Disorders in Europe is featured, and can be [...]
Event Report: “Brain Research in Europe: Shaping FP9 and Delivering Innovation to the Benefit of Patients” & Brain Mission launch
Last Monday and Tuesday, 23-24 April 2018, EBC held the two-day event "Brain Research in Europe: Shaping FP9 and Delivering Innovation to the Benefit of Patients" at the University Foundation in Brussels. The event was organised in three different sessions: "FP9 and Missions", "The Value of Innovation" and "European Brain Research: Shifting Gears and Going Global". The full programme booklet [...]
The use of off-label medicines in Spain: Finding the right balance between the need for safe access to care and the maintenance of highest standards of care for patients
Madrid, 25 April 2018 – On this day, the Spanish Brain Council, in collaboration with the European Brain Council, is delighted to organise a roundtable discussion on the off-label use of medicines. The event will bring together around 20 experts and representatives of patient associations, medical societies, as well as pharmaceutical companies, to discuss the conditions for the correct prescription [...]